BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9063480)

  • 41. [Adjuvant chemotherapy of paclitaxel plus carboplatin in uterine corpus cancer--comparison with cisplatin, adriamycin plus cyclophosphamide].
    Tanase Y; Kawaguchi R; Haruta S; Kanayama S; Yamada Y; Kobayashi H
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):945-50. PubMed ID: 16835485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemotherapy for recurrent cervical cancer.
    Pectasides D; Kamposioras K; Papaxoinis G; Pectasides E
    Cancer Treat Rev; 2008 Nov; 34(7):603-13. PubMed ID: 18657909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monitoring the cytotoxic potential of a sequential polychemotherapy (adriamycin/cisplatin-vincristine/cyclophosphamide-high dose methotrexate) in patients with advanced ovarian cancer with the tumor marker CA-125.
    Sevelda P; Dittrich C; Salzer H; Pateisky N; Spona J
    Cancer Detect Prev; 1986; 9(5-6):521-8. PubMed ID: 3465442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The clinical effect of hyperthermia combined with induced hypertension chemotherapy].
    Hayashida S; Sugimoto K; Kobayashi T
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1218-24. PubMed ID: 6203489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of gynecologic neoplasms in internal medicine].
    Mayr AC
    Schweiz Med Wochenschr; 1978 Sep; 108(35):1369-73. PubMed ID: 80032
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Ambulatory use of cisplatin. Preliminary considerations].
    de Oliveira Filho JA; da Cunha FM
    Rev Paul Med; 1983; 101(5):199-202. PubMed ID: 6200911
    [No Abstract]   [Full Text] [Related]  

  • 47. [Outpatient chemotherapy in gynecologic oncology].
    Jobo T
    Gan To Kagaku Ryoho; 2006 Dec; 33 Suppl 2():369-71. PubMed ID: 17469390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemotherapy of cervical cancer.
    Guthrie D
    Clin Obstet Gynaecol; 1985 Mar; 12(1):229-46. PubMed ID: 3922658
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Phase II study of 4'-O-tetrahydropyranyl-adriamycin (THP-ADM) in patients with gynecological cancer].
    Kato T; Nishimura H; Umezu J; Takeuchi S; Kanazawa K; Inoue H; Suzuki M; Hirono M; Suzuki T; Okajima H
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):1962-7. PubMed ID: 4051511
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical study of intraperitoneal chemotherapeutic perfusion (IPCP) of mitomycin C (MMC) and intraperitoneal administration of cisplatin].
    Yamashita S; Ito T; Kinashi N; Yakabe A
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2458-63. PubMed ID: 3113338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [New regimens for the treatment of gynecologic cancers].
    Sugiyama T; Ushijima K; Kamura T
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):375-81. PubMed ID: 10740630
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Possibilities of drug therapy of gynecologic malignancies].
    Armborst V
    Med Welt; 1967 Oct; 42():2498-501. PubMed ID: 4306391
    [No Abstract]   [Full Text] [Related]  

  • 53. [A case report of advanced ovarian cancer with chronic renal dysfunction treated by CDDP i.p].
    Maruyama M; Noda T; Kiyozuka Y; Oku M; Ninomiya Y; Ibaraki T; Katoh Y; Itani Y; Okamura Y; Beppu K
    Gan No Rinsho; 1988 May; 34(6):815-9. PubMed ID: 3379761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemotherapy for advanced cervical cancer with bleomycin, vincristine, mitomycin C, and cis-diamminedichloroplatinum(II) (BOMP).
    Vogl SE; Moukhtar M; Calanog A; Greenwald EH; Kaplan BH
    Cancer Treat Rep; 1980; 64(8-9):1005-7. PubMed ID: 6160911
    [No Abstract]   [Full Text] [Related]  

  • 55. Ifosfamide in the management of gynecologic cancers.
    Thigpen T; Lambuth BW; Vance RB
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):11-8. PubMed ID: 2185545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical experience with the chemotherapy of gynecologic cancer].
    Dvorák O; Slavík V; Chmelík V
    Zentralbl Gynakol; 1977; 99(24):1495-501. PubMed ID: 580128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemotherapy for advanced or recurrent gynecologic cancer.
    Thigpen T; Vance R; Lambuth B; Balducci L; Khansur T; Blessing J; McGehee R
    Cancer; 1987 Oct; 60(8 Suppl):2104-16. PubMed ID: 3308070
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Criteria for the determination of the immediate efficacy of chemotherapy in gynecologic neoplasms].
    Koto T; Tsunawaki A
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):4262-76. PubMed ID: 3729501
    [No Abstract]   [Full Text] [Related]  

  • 59. Gynecologic malignancies.
    Schaebler DL; Schilder RJ; Young RC
    Cancer Chemother Biol Response Modif; 1994; 15():555-80. PubMed ID: 7779599
    [No Abstract]   [Full Text] [Related]  

  • 60. Phase II study of mitomycin, doxorubicin, and cisplatin in the treatment of advanced uterine leiomyosarcoma: a Gynecologic Oncology Group study.
    Edmonson JH; Blessing JA; Cosin JA; Miller DS; Cohn DE; Rotmensch J
    Gynecol Oncol; 2002 Jun; 85(3):507-10. PubMed ID: 12051882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.